GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 81 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,836 | +106.8% | 13,456 | +55.1% | 0.00% | – |
| Q2 2023 | $12,492 | +95992.3% | 8,675 | +39.5% | 0.00% | – |
| Q1 2023 | $13 | -7.1% | 6,219 | -48.7% | 0.00% | -100.0% |
| Q4 2022 | $14 | -99.9% | 12,121 | +64.2% | 0.00% | – |
| Q3 2022 | $12,000 | +33.3% | 7,381 | +3.2% | 0.00% | – |
| Q2 2022 | $9,000 | +125.0% | 7,150 | +192.2% | 0.00% | – |
| Q1 2022 | $4,000 | -78.9% | 2,447 | -73.9% | 0.00% | – |
| Q4 2021 | $19,000 | +58.3% | 9,387 | +205.5% | 0.00% | – |
| Q3 2021 | $12,000 | -63.6% | 3,073 | -69.9% | 0.00% | -100.0% |
| Q2 2021 | $33,000 | +200.0% | 10,202 | +101.5% | 0.00% | – |
| Q1 2021 | $11,000 | -70.3% | 5,064 | -69.6% | 0.00% | -100.0% |
| Q4 2020 | $37,000 | -67.5% | 16,675 | -61.1% | 0.00% | 0.0% |
| Q3 2020 | $114,000 | +338.5% | 42,866 | +400.7% | 0.00% | 0.0% |
| Q2 2020 | $26,000 | +550.0% | 8,562 | +300.3% | 0.00% | – |
| Q1 2020 | $4,000 | 0.0% | 2,139 | +118.7% | 0.00% | – |
| Q3 2019 | $4,000 | -76.5% | 978 | -75.8% | 0.00% | -100.0% |
| Q2 2019 | $17,000 | -56.4% | 4,033 | -46.8% | 0.00% | -50.0% |
| Q1 2019 | $39,000 | -23.5% | 7,584 | -10.1% | 0.00% | -50.0% |
| Q3 2018 | $51,000 | +628.6% | 8,434 | +670.9% | 0.00% | – |
| Q2 2018 | $7,000 | – | 1,094 | +1723.3% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 60 | -99.3% | 0.00% | -100.0% |
| Q4 2015 | $15,000 | +1400.0% | 8,872 | +2556.3% | 0.00% | – |
| Q3 2015 | $1,000 | -66.7% | 334 | -56.8% | 0.00% | – |
| Q2 2015 | $3,000 | 0.0% | 773 | -20.6% | 0.00% | – |
| Q1 2015 | $3,000 | -89.3% | 974 | -88.2% | 0.00% | -100.0% |
| Q4 2014 | $28,000 | -22.2% | 8,243 | +16.7% | 0.00% | -25.0% |
| Q3 2014 | $36,000 | -82.1% | 7,063 | -51.6% | 0.00% | -84.6% |
| Q2 2014 | $201,000 | +9950.0% | 14,606 | +14506.0% | 0.03% | – |
| Q1 2014 | $2,000 | -93.3% | 100 | -97.3% | 0.00% | -100.0% |
| Q4 2013 | $30,000 | -37.5% | 3,754 | -22.2% | 0.01% | 0.0% |
| Q3 2013 | $48,000 | – | 4,823 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |